SADRP: A structurally aware multi-modal framework for drug response prediction
SADRP combines drug topology, chemical-bond information, gene expression and DNA methylation to predict drug sensitivity across cancer cell lines.
SADRP combines drug topology, chemical-bond information, gene expression and DNA methylation to predict drug sensitivity across cancer cell lines.
A comprehensive review finds that AML cells commonly overcome epigenetic drugs through compensatory chromatin and transcriptional adaptation, favoring biomarker-selected combinations ...
A single-individual study assembled the goonch catfish mitogenome, resolved B. bagarius as sister to B. yarrelli and identified unvalidated candidate ...
A 2026 review found encouraging diagnostic results for DNA methylation biomarkers in ovarian cancer but concluded that prospective evidence at ...
A 2026 review finds that epigenetic changes sustain PI3K/AKT signaling in hepatocellular carcinoma, while experimental evidence indicates activated signaling can ...
A new study links declining methylation of the ESR2 promoter to rising gene expression in sheep ovaries as puberty begins, ...
A targeted epigenomic study of advanced carotid plaques reveals coordinated DNA hypomethylation of microRNA regulatory regions linked to plaque instability, ...
A Nature Genetics study shows that the histone mark H2Aub laid down by PRC1 guides the reestablishment of Polycomb repression, ...
A pilot multi-omics study links disrupted sleep timing, specific gut microbial signatures, and altered DNA methylation at neural-related genes in ...
A new study links methylation changes in the KDM5 gene family and cofactors, measured in blood before and after neoadjuvant ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine